CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 99 enrolled
Drug / intervention
bupropion-SR +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02162862
NCT02162862Phase 4Completed
CompareCT.gov

Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness

Eva Szigethy·interventional·Posted Jun 13, 2014·Updated Sep 13, 2017

In Brief

A Phase 4 clinical trial evaluating Behavioral Counseling and bupropion-SR for Sleep Disturbance and 2 related conditions. Completed, enrolled 99 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine if either a targeted type of talk therapy (Phase I) or medication, Wellbutrin, (Phase II) improve sleep disturbance and/or fatigue in individuals with Inflammatory Bowel Disease (IBD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSleep Disturbance, Fatigue, Inflammatory Bowel Disease
CountriesUnited States
CollaboratorsCrohn's and Colitis Foundation

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 13, 2014
Enrollment StartJul 1, 2013
Primary CompletionJun 30, 2016
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 12.1 years ago

Interventions

Behavioral Counselingbehavioral

bupropion-SRdrug